The global orthopedic surgical robotic device market will grow rapidly through 2027, driven by increasing penetration of this currently underused technology, expanding treatable populations, and an increase in clinical evidence that supports the benefits of robotic surgery.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for orthopedic surgical robotic devices in US, Europe, and Asia Pacific across a 10-year period.
Expansion into new indications is increasing the total treatable population and driving growth in the orthopedic surgical robotic market.
What is the penetration of robotics into the various orthopedic procedures?
Which robotic-assisted procedures will see the highest growth?
How does the penetration and growth of robotic-assisted procedures differ between geographical regions?
Competition in this market is becoming more intense as new robotic systems receives regulatory approval
Who are the competitors in this market and what are their strengths and weaknesses?
What are the key strategies adopted by these competitors and how will it impact the competitive landscape?
Who are the likely new entrants into this market going forward?
The orthopedic surgical robotic market is hindered by cost and availability of alternative technologies.
What are the alternative technologies that could also improve clinical outcomes?
How will the cost of robotic systems change through 2027?
- Orthopedic Surgical Robotic Devices - Market Insights - Global
Author(s): Xi Chen, PhD; Lucy Sha Guan, MSc
Xi Chen is a principal analyst on the Medtech Insights team at Decision Resources Group and currently serves as the in-house expert in general surgery, gastroenterology, ENT, and robotic surgery markets. Xi has been instrumental in improving the team’s market modeling capabilities and has also helped broaden the team’s expertise in leveraging medical claims and hospital purchase order data to perform market sizing and competitive analysis. Xi has been featured in several industry publications, particularly for his expertise in the robotic surgery market. Xi holds a Ph.D. in Biomedical Engineering from the University of Toronto.
Lucy Guan is a senior analyst within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group, with extensive knowledge in the markets for endoscope servicing, video and high-tech hardware devices, and laparoscopic devices. Lucy holds an Honors Bachelor's degree in Biochemistry and Health & Disease and a Master's degree in Medical Science from the University of Toronto.